FindTrial
Sign In

COMPARISON OF HEARING LOSS IN PATIENTS RECEIVING DIFFERENT TYPES OF RADIATIONS FOR HEAD AND NECK CANCERS

COMPARISON OF HEARING LOSS IN PATIENTS RECEIVING DIFFERENT MODALITIES OF RADIOTHERAPY I.E 2DRT, 3DRT AND IMRT IN HEAD AND NECK MALIGNANCIES

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/08/004939
Enrollment
50
Registered
2014-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SUFFERING FROM HEAD AND NECK MALIGNANCIES

Interventions

None listed

Sponsors

FATHER MULLER MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals receiving either of the modalities of radiation for head and neck tumors where the auditory system is included in the field of radiation. 2.Individuals coming for atleast 3 months follow up. 3.Individuals willing to participate in the study.

Exclusion criteria

Exclusion criteria: Individuals who have congenital hearing loss. have undergone otological surgery in the past. have a hearing loss of more than 55 dB prior to therapy.

Design outcomes

Primary

MeasureTime frame
Outcome in the form of decibles of hearing loss as obtained from a pure tone audiogram (PTA).Timepoint: PRE THERAPY, 3 WEEKS AFTER INITIATING THERAPY, AT THE COMPLETION OF THERAPY, 3 MONTHS FOLLOW UP—

Secondary

MeasureTime frame
DEGREE OF SEVERITY AND TYPE OF HEARING LOSSTimepoint: PRE THERAPY, 3 WEEKS AFTER INITIATING THERAPY, AT THE COMPLETION OF THERAPY, 3 MONTHS FOLLOW UP—

Countries

India

Contacts

Public ContactDR MAHESH BHAT

FATHER MULLER MEDICAL COLLEGE

mahesh.t.bhat@gmail.com9886734374

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026